BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6541192)

  • 1. Role of bacterial lipopolysaccharide and lymphokine in the regulation of macrophage activation: correlates between secretion of plasminogen activator and tumor lysis.
    Jones CM; Taramelli D; Clouse CA; Goldfarb RG
    Immunobiology; 1984 May; 166(4-5):410-27. PubMed ID: 6541192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cyclic AMP-dependent protein kinase isozyme expression associated with activation of a macrophage cell line.
    Justement LB; Aldrich WA; Wenger GD; O'Dorisio MS; Zwilling BS
    J Immunol; 1986 Jan; 136(1):270-7. PubMed ID: 2999244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
    Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
    Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and lipopolysaccharide (LPS).
    Singh SM; Singh RK; Sodhi A
    Neoplasma; 1992; 39(3):151-5. PubMed ID: 1528319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-induced secretion of plasminogen activator by murine macrophages.
    Klimetzek V; Sorg C
    Eur J Immunol; 1977 Mar; 7(3):185-7. PubMed ID: 862658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
    Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
    Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.
    Johnson WJ; Marino PA; Schreiber RD; Adams DO
    J Immunol; 1983 Aug; 131(2):1038-43. PubMed ID: 6306103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: relationship to activation for macrophage tumoricidal function.
    Hamilton TA; Jansen MM; Somers SD; Adams DO
    J Cell Physiol; 1986 Jul; 128(1):9-17. PubMed ID: 3087999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
    Ohyama K
    Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E; Ulich T; Schreiber RD
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.